In Section A, contributors will receive unique doses and schedules of oral ABBV-744 pill to recognize Harmless dosing regimen. Further members is going to be enrolled at the recognized monotherapy dosign routine. In Section B, members will acquire oral ruxolitinib and ABBV-744 will likely be supplied as "add-on" therapy. In https://beckettykwht.blogsvirals.com/31315435/indicators-on-clinical-trial-recruitment-for-abbv-744-study-you-should-know